ZYUS Life Sciences Corp. is a Canadian-based life sciences company. It focuses on the global development and commercialization of cannabinoid based pharmaceutical drug product candidates and exempt market therapeutics. The firm offers cGMP/EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The company was founded by Zettl Harold Brent on April 3, 2018 and is headquartered in Saskatoon, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ZYUS Life Sciences Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ZYUS Life Sciences Corporation market cap is $36M.
What is the 52-week high for ZYUS Life Sciences Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ZYUS Life Sciences Corporation 52 week high is $0.74 as of October 01, 2025.
What is the 52-week low for ZYUS Life Sciences Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ZYUS Life Sciences Corporation 52 week low is $0.0005 as of October 01, 2025.
What is ZYUS Life Sciences Corporation stock price today?
ZYUS Life Sciences Corporation stock price today is $0.5323.
What was ZYUS Life Sciences Corporation stock price yesterday?
ZYUS Life Sciences Corporation stock price yesterday was $0.3985.
What is the PE ratio of ZYUS Life Sciences Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ZYUS Life Sciences Corporation’s P/E ratio is -1.62.
What is the Price-to-Book ratio of ZYUS Life Sciences Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ZYUS Life Sciences Corporation P/B ratio is -5.7577.
What is the 50-day moving average of ZYUS Life Sciences Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ZYUS Life Sciences Corporation 50-day moving average is $0.4947.